We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$17.2M
Cap. Flow
-$1.31M
Cap. Flow %
-0.43%
Top 10 Hldgs %
39.76%
Holding
80
New
1
Increased
8
Reduced
38
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.66M
2
NVS icon
Novartis
NVS
+$488K
3
GE icon
GE Aerospace
GE
+$177K
4
CVS icon
CVS Health
CVS
+$167K
5
SLB icon
SLB Ltd
SLB
+$90.5K

Top Sells

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$923K
2
SVU
SUPERVALU Inc.
SVU
+$708K
3
LVLT
Level 3 Communications Inc
LVLT
+$282K
4
DO
Diamond Offshore Drilling
DO
+$261K
5
INTC icon
Intel
INTC
+$140K

Sector Composition

Rank Sector Weight
1 Healthcare 27.94%
2 Industrials 23%
3 Technology 16.75%
4 Energy 9.09%
5 Consumer Staples 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
26
Stryker
SYK
$129B
$4.57M 1.5%
29,504
-400
-1% -$61K
ADP icon
27
Automatic Data Processing
ADP
$107B
$4.53M 1.49%
38,654
-675
-2% -$77.2K
CSCO icon
28
Cisco
CSCO
$479B
$4.28M 1.41%
111,631
– –
EQT icon
29
EQT Corp
EQT
$32B
$4.2M 1.38%
135,672
– –
MDT icon
30
Medtronic
MDT
$110B
$4.12M 1.36%
50,996
-32
-0.1% -$2.56K
VAR
31
DELISTED
Varian Medical Systems, Inc.
VAR
$3.94M 1.3%
35,400
-242
-0.7% -$26K
FLS icon
32
Flowserve
FLS
$10B
$3.79M 1.25%
90,016
+1,817
+2% +$76.1K
PFE icon
33
Pfizer
PFE
$147B
$3.59M 1.18%
104,543
+632
+0.6% +$21.6K
HSY icon
34
Hershey
HSY
$36.1B
$3.58M 1.18%
31,535
– –
KMPR icon
35
Kemper
KMPR
$1.72B
$3.57M 1.18%
51,877
– –
CVS icon
36
CVS Health
CVS
$126B
$3.1M 1.02%
42,726
+2,300
+6% +$167K
QEP
37
DELISTED
QEP RESOURCES, INC.
QEP
$2.87M 0.95%
300,185
-11,928
-4% -$108K
WFC icon
38
Wells Fargo
WFC
$270B
$2.79M 0.92%
46,036
-651
-1% -$36.8K
NOV icon
39
NOV
NOV
$6.95B
$2.53M 0.83%
70,280
-3,194
-4% -$108K
WAFD icon
40
WaFd
WAFD
$2.79B
$2.2M 0.72%
64,207
– –
STT icon
41
State Street
STT
$51.4B
$1.9M 0.63%
19,474
– –
GLW icon
42
Corning
GLW
$135B
$1.88M 0.62%
58,741
– –
DO
43
DELISTED
Diamond Offshore Drilling
DO
$1.75M 0.58%
94,056
-16,036
-15% -$261K
PPG icon
44
PPG Industries
PPG
$26.5B
$1.67M 0.55%
14,320
– –
KEYS icon
45
Keysight
KEYS
$57.4B
$1.6M 0.53%
38,481
– –
BP icon
46
BP
BP
$106B
$1.54M 0.51%
39,948
-601
-1% -$21.8K
CELG
47
DELISTED
Celgene Corp
CELG
$1.54M 0.51%
+14,732
New +$1.66M
CVX icon
48
Chevron
CVX
$366B
$1.52M 0.5%
12,118
– –
GE icon
49
GE Aerospace
GE
$396B
$1.5M 0.5%
17,987
+1,857
+12% +$177K
RDS.A
50
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.5M 0.49%
22,440
– –
1
2
3 4

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Rubinstein Investment Management held 80 positions worth $304M, up 6% from $287M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.8%. Thompson Rubinstein Investment Management opened 1 new position and exited 2, leaving the 80-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q4 2017 buy was Celgene Corp: 14,732 shares worth $1.54M.
  • Thompson Rubinstein Investment Management added most to Novartis in Q4 2017, an estimated $488K increase.
  • Thompson Rubinstein Investment Management's biggest Q4 2017 reduction was Bruker, cutting an estimated $923K.
  • Thompson Rubinstein Investment Management fully exited SUPERVALU Inc. in Q4 2017, selling an estimated $708K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $304M portfolio in Q4 2017.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 2 in Q4 2017.
  • Thompson Rubinstein Investment Management's portfolio value rose 6% quarter-over-quarter to $304M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q4 2017, filed 17 Jan 2018.